Strategies for Addressing Vaccine Hesitancy
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Human Vaccines and Public Health".
Deadline for manuscript submissions: 20 December 2024 | Viewed by 293
Special Issue Editor
Interests: Zika virus pathobiology; cytomegalovirus pathobiology and vaccines; COVID-19 vaccines and health disparities; monkeypox; emerging pathogens
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Vaccine hesitancy, or the delay in accepting or refusing vaccines despite the availability of vaccination services, is a significant contributor to health disparities. Vaccine hesitancy is often caused by misinformation and disinformation, especially among medically underserved populations and those with low levels of health literacy. Vaccine awareness and education are important. Combating misinformation; supporting health literacy; vaccine access; vaccine champions for training, education, and advocacy; and innovative learning strategies can surmount vaccine hesitancy. This Special Issue will focus on laboratory and clinical vaccine research, utilization, and immunization strategies to reduce vaccine hesitancy, which may include long-term, cost-effective approaches to reduce vaccine-preventable disease burden. Circumstances within the scope of Vaccines that affect vaccine complacency, convenience, and confidence are of interest.
Dr. Donald J. Alcendor
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccines
- vaccine hesitancy
- vaccine uptake
- vaccine misinformation
- vaccine disparities
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
